CMS Announces Significant 2027 Reductions on 15 High-Cost Medicare Drugs
CMS sets 2027 maximum fair prices for 15 high-cost Medicare drugs, cutting costs by up to 85% and saving $12 billion annually under Inflation Reduction Act measures.
Zing Health Sues HHS and CMS Over Medicare Part D Termination and Ratings Dispute
Zing Health sues HHS and CMS over improper Medicare Part D termination and star rating methodology disputes, claiming significant financial and reputational damages.
CMS Proposes Key Changes to Medicare Advantage Star Ratings and Regulatory Streamlining for 2027
CMS releases 2027 Medicare Advantage and Part D proposed rule focusing on Star Ratings adjustments, regulatory burden reduction, and program spending projections.
CMS Proposed 2027 Medicare Advantage and Part D Changes Focus on Simplification and Oversight
CMS releases Proposed 2027 Rules for Medicare Advantage and Part D, emphasizing Star Ratings simplification, marketing oversight updates, expanded risk adjustment data use, and Part D redesign implementation.
Medicare 2026: Rising Costs and Fewer Plan Options Challenge Beneficiaries
Medicare beneficiaries face higher Part B premiums, fewer Part D plans, and Medicare Advantage cancellations in 2026, making open enrollment critical for coverage decisions.
CMS Proposes 2027 Medicare Advantage Rule Updates on Star Ratings, Risk Adjustment, and Reporting
CMS released 2027 proposed Medicare Advantage rules focusing on simplifying Star Ratings, expanding risk adjustment data use, and streamlining reporting requirements.
Medicare 2026: Rising Part B Costs, Shrinking Part D Plans, and Advantage Changes
Medicare in 2026 will see notable premium hikes, fewer prescription drug plans, and changes in Medicare Advantage availability. Understand the impact on coverage choices and costs to prepare for open enrollment.
Medicare Drug Price Negotiations Yield 44% Savings Under Inflation Reduction Act
Medicare's Inflation Reduction Act negotiations cut prices for 15 top prescription drugs by 44%, reducing out-of-pocket costs and impacting Medicare Part D and Part B markets.
Medicare Premiums and Plan Changes Signal Market Shifts for 2026
Medicare 2026 premiums surge nearly 10%, with fewer Medicare Advantage plans as insurers scale back. Explore key Medicare cost drivers and market impacts.
Medicare LI NET Program Offers Temporary Drug Coverage for Low Income Beneficiaries
The Medicare LI NET program provides temporary prescription drug coverage without restrictions to low income beneficiaries not yet enrolled in a Part D plan, ensuring seamless access during the transition period.